704 related articles for article (PubMed ID: 28265777)
1. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
3. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
[TBL] [Abstract][Full Text] [Related]
4. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
5. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.
Sinno AK; Fader AN; Roche KL; Giuntoli RL; Tanner EJ
Gynecol Oncol; 2014 Aug; 134(2):281-6. PubMed ID: 24882555
[TBL] [Abstract][Full Text] [Related]
6. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
Holloway RW; Bravo RA; Rakowski JA; James JA; Jeppson CN; Ingersoll SB; Ahmad S
Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
8. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: a prospective study.
López-De la Manzanara Cano C; Cordero García JM; Martín-Francisco C; Pascual-Ramírez J; Parra CP; Céspedes Casas C
Int J Gynecol Cancer; 2014 Jul; 24(6):1048-53. PubMed ID: 24927249
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
11. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green.
Martinelli F; Ditto A; Bogani G; Signorelli M; Chiappa V; Lorusso D; Haeusler E; Raspagliesi F
J Minim Invasive Gynecol; 2017 Jan; 24(1):89-93. PubMed ID: 27725278
[TBL] [Abstract][Full Text] [Related]
13. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
Naaman Y; Pinkas L; Roitman S; Ikher S; Oustinov N; Vaisbuch E; Yachnin A; Ben-Arie A
Ann Surg Oncol; 2016 Feb; 23(2):450-5. PubMed ID: 26438438
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
16. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
[TBL] [Abstract][Full Text] [Related]
17. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
[No Abstract] [Full Text] [Related]
19. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
[TBL] [Abstract][Full Text] [Related]
20. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
